This report provides a definitive analysis for venture capital (VC) investment in the value-based care (VBC) healthtech sector. While VBC represents a profound and necessary paradigm shift with a multi-trillion-dollar market opportunity, it is not an environment for unsophisticated capital. The core finding is a qualified "yes": venture capital should strategically back VBC healthtech, but only by targeting specific business models and deploying patient capital with a deep

Subconscious vibro-tactile stimulation (VTS) represents a powerful, emerging modality within the HealthTech sector, positioned to transition from a specialised clinical tool to a ubiquitous component of personalised healthcare. Defined as the application of non-invasive mechanical vibration to the skin to modulate neural activity, VTS operates on an implicit level, leveraging the body's natural sensory and proprioceptive systems to effect therapeutic changes in the brain and

For High-Growth HealthTech Startups: When planning a fundraising or exit event, it is recommended to engage with a specialised boutique advisor like Nelson Advisors, with their "founders for founders" approach, they can offer a more tailored and empathetic perspective. Their deep understanding of the market niche and hands-on guidance can be more valuable for maximising shareholder value than the broad, standardised services of a larger generalist firm.

TIME has released its inaugural "World's Top HealthTech Companies 2025" list, in partnership with Statista. The ranking highlights 400 companies from over 25 countries across six market segments. The companies were evaluated based on a combination of financial performance, reputation analysis, and online engagement.

The current healthcare innovation economy presents a compelling and complex paradox for investors. The broader US healthcare venture capital fundraising landscape has experienced a significant decline, with the total for the first half of 2025 at just $3 Billion, a steep drop from the previous year. This puts the sector on track for its worst fundraising year in over a decade. This market contraction is largely attributed to economic and political uncertainty, coupled with a

Nelson Advisors Partner Lloyd Price will Chair the panel discussing the European HealthTech Investment Landscape, covering key questions such as: Which countries or regions in Europe are emerging as HealthTech hubs? Beyond the traditional powerhouses like the UK, Germany, and France, are there new centers of innovation, particularly in Central and Eastern Europe (CEE)? How are macroeconomic factors impacting the market? How are rising interest rates and inflation affecting d

This report provides a detailed analysis of Nelson Advisors, a highly specialised mergers and acquisitions (M&A), partnerships and investment advisory firm. The firm is exclusively dedicated to the dynamic European medical technology (MedTech) sector, with an extended reach into the UK and North America. The analysis reveals that the firm's primary competitive advantage is rooted in its unique "Founders for Founders" approach, which is underpinned by the direct entrepreneuria

The health technology sector is experiencing a period of intense focus on artificial intelligence, driven by an "AI-first" narrative that has captivated investors and dominated industry discourse. This report posits that this concentrated market behaviour, characterised by an investment "gold rush," presents a profound opportunity for a contrarian business strategy. The prevailing AI narrative, much like other market frenzies, has led to a collective overvaluation of a single

The global HealthTech landscape is undergoing a profound structural transformation. A confluence of economic headwinds in mature markets, particularly in North America and a recalibration of investor sentiment away from speculative growth has positioned cross-border mergers and acquisitions (M&A) as the primary engine of strategic growth and liquidity. This report presents a detailed analysis of this new paradigm, arguing that strategic buyers, from big Pharma and health

Nelson Advisors featured in the PMLiVE article 'The digital prescription: enhancing the patient experience with technology' Nelson...

Nelson Advisors thought leadership blog 'Healthcare.Digital' has featured in the Tony Blair Institute for Global Change publication 'The NHS at a Crossroads: The App That Can Transform Britain’s Health' highlighting the scale and importance of Doctolib in the French HealthTech market.

The healthcare industry is in the midst of a profound transformation, driven by the convergence of digital platforms, a growing abundance of health data, and the analytical power of artificial intelligence (AI). This shift is not merely an incremental improvement but a fundamental re-architecture of care delivery, moving toward models that are more proactive, personalised, and efficient. The market for these technologies is expanding at an unprecedented rate, creating a clear

The speculative "gold rush" in healthcare artificial intelligence, characterised by a feverish pace of unbridled investment and a technology-first approach to product development, has concluded. A new, more discerning market has emerged, defined not by the promise of an algorithm but by a strategic fusion of technological efficacy, market access, and quantifiable value. This report provides a detailed analysis of this new equilibrium. The distinction between "thrivers" an

The MedTech sector in 2026 stands at a pivotal juncture, defined by the convergence of rapid technological innovation, a maturing market demanding proven value, and a complex policy landscape. This report synthesizes these forces, moving from a macro-level analysis to specific, actionable insights. The industry is shifting from a focus on siloed technological advancements to an integrated, interconnected ecosystem where success hinges on the ability to operationalise innovati

The analysis of Nelson Advisors reveals a sophisticated and highly specialised boutique investment banking firm whose value proposition is built on a unique confluence of expertise. The firm's exclusive focus on the European HealthTech sector is a powerful competitive differentiator, allowing it to provide a level of nuanced, industry-specific advisory that generalist firms cannot match. The "Founders for Founders" approach, which is the cornerstone of its identity, is a stra